glp 1 vs glucagon New strategies for the treatment of obesity and metabolic dysfunctions GLP-1 Medications – Community Education

Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase b (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase a (PKA) signaling pathways involving -catenin

& Lundwall, A

Wegovy has been recommended for PBS subsidy only for a narrower group of people with obesity and established cardiovascular disease, subject to listing conditions and access criteria

This extended pharmacokinetic profile allows the investigation of sustained amylin receptor engagement over longer periods than would be possible with native amylin